1. Zimmer SM, Burke DS. Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med. 2009. 361:279–285.
Article
2. Treanor JJ. Mandell GL, Bennett JE, Dolin R, editors. Influenza virus. Principles and practice of infectious diseases. 2005. 6th ed. New York: Elsevier Churchill Livingstone;2060–2085.
3. Sonoguchi T, Sakoh M, Kunita N, Satsuta K, Noriki H, Fukumi H. Reinfection with influenza A (H2N2, H3N2, and H1N1) viruses in soldiers and students in Japan. J Infect Dis. 1986. 153:33–40.
Article
4. Perez CM, Ferres M, Labarca JA. Pandemic (H1N1) 2009 reinfection, Chile. Emerg Infect Dis. 2010. 16:156–157.
Article
5. Kim BN, Kwak YG, Moon CS, Kim YS, Kim ES, Bae IG, Yeom JS, Lee CS. Trend in Age Distribution of Visitors to Fluclinics during the Pandemic Influenza (H1N1 2009). Infect Chemother. 2010. 42:90–94.
Article
6. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008. 167:775–785.
Article
7. Aoki FY, Boivin G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. J Clin Virol. 2009. 44:255–261.
Article
8. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG. US OralNeuraminidase Study Group. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000. 283:1016–1024.
Article
9. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000. 355:1845–1850.
Article
10. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C. National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009. 361:2507–2517.
Article
11. Gomes MG, White LJ, Medley GF. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol. 2004. 228:539–549.
Article
12. Gökaydin D, Oliveira-Martins JB, Gordo I, Gomes MG. The reinfection threshold regulates pathogen diversity: the case of influenza. J R Soc Interface. 2007. 4:137–142.
Article